The Ews-ERG Fusion Protein Can Initiate Neoplasia from Lineage-Committed Haematopoietic Cells

The EWS-ERG fusion protein is found in human sarcomas with the chromosomal translocation t(21;22)(q22;q12), where the translocation is considered to be an initiating event in sarcoma formation within uncommitted mesenchymal cells, probably long-lived progenitors capable of self renewal. The fusion protein may not therefore have an oncogenic capability beyond these progenitors. To assess whether EWS-ERG can be a tumour initiator in cells other than mesenchymal cells, we have analysed Ews-ERG fusion protein function in a cellular environment not typical of that found in human cancers, namely, committed lymphoid cells. We have used Ews-ERG invertor mice having an inverted ERG cDNA cassette flanked by loxP sites knocked in the Ews intron 8, crossed with mice expressing Cre recombinase under the control of the Rag1 gene to give conditional, lymphoid-specific expression of the fusion protein. Clonal T cell neoplasias arose in these mice. This conditional Ews gene fusion model of tumourigenesis shows that Ews-ERG can cause haematopoietic tumours and the precursor cells are committed cells. Thus, Ews-ERG can function in cells that do not have to be pluripotent progenitors or mesenchymal cells.

[1]  G. Thomas,et al.  EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts , 1993, Nature Genetics.

[2]  I. Weissman,et al.  Expression of BCR/ABL and BCL-2 in myeloid progenitors leads to myeloid leukemias , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Lefranc,et al.  Diversity and rearrangement of the human T cell rearranging γ genes: Nine germ-line variable genes belonging to two subgroups , 1986, Cell.

[4]  R. Larson,et al.  Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma , 1993, Nature Genetics.

[5]  C. Cooper,et al.  Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. , 1996, Oncogene.

[6]  Mathieu Rouard,et al.  IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. , 2005, Developmental and comparative immunology.

[7]  Marie-Paule Lefranc,et al.  IMGT, the international ImMunoGeneTics database: a high-quality information system for comparative immunogenetics and immunology. , 2002, Developmental and comparative immunology.

[8]  P. Sorensen,et al.  A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERG , 1994, Nature Genetics.

[9]  E. Simpson,et al.  Inter‐chromosomal recombination of Mll and Af9 genes mediated by cre‐loxP in mouse development , 2000, EMBO reports.

[10]  M. Ouchida,et al.  TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. , 1994, Oncogene.

[11]  A. Sandberg.  Genetics of chondrosarcoma and related tumors , 2004, Current opinion in oncology.

[12]  F. Alt,et al.  Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion. , 1999, Immunity.

[13]  I. Weissman,et al.  Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. , 2003, Genes & development.

[14]  M. Höglund,et al.  Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22) , 1994, Genes, chromosomes & cancer.

[15]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[16]  T. Rabbitts,et al.  Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. , 2003, Cancer cell.

[17]  J. Buer,et al.  Essential role of the pre-T cell receptor in allelic exclusion of the T cell receptor beta locus. , 1997, Immunity.

[18]  V. Giudicelli,et al.  IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. , 2003, Developmental and comparative immunology.

[19]  T. Rabbitts,et al.  The invertor knock-in conditional chromosomal translocation mimic , 2004, Nature Methods.

[20]  G. Thomas,et al.  A new member of the ETS family fused to EWS in Ewing tumors , 1997, Oncogene.

[21]  N. Mandahl,et al.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma , 1993, Nature.

[22]  T. Rabbitts,et al.  Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. , 2004, Genes & development.

[23]  Christopher T Denny,et al.  Biology of EWS/ETS fusions in Ewing's family tumors , 2001, Oncogene.

[24]  J. Pelletier,et al.  The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties , 1998, Oncogene.

[25]  M. Cleary,et al.  Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins , 2001, Oncogene.

[26]  M. Surani,et al.  Isotype exclusion and transgene down-regulation in immunoglobulin-λ transgenic mice , 1989, Nature.

[27]  Y. Hayashi,et al.  An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. , 1994, Cancer research.

[28]  Tak W. Mak,et al.  Mouse T cell antigen receptor: Structure and organization of constant and joining gene segments encoding the β polypeptide , 1984, Cell.

[29]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[30]  T. Rabbitts,et al.  An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion Oncogenes , 1996, Cell.

[31]  N. Harris,et al.  Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.

[32]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[33]  C. Denny,et al.  A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. , 1995, Oncogene.

[34]  D. Gilliland,et al.  Leukaemia stem cells and the evolution of cancer-stem-cell research , 2005, Nature Reviews Cancer.

[35]  M. Höglund,et al.  Fusion of the EWS and CHOP genes in myxoid liposarcoma. , 1996, Oncogene.

[36]  E. Canaani,et al.  Chronic myelogenous leukemia: biology and therapy. , 1993, Leukemia.

[37]  F. Barr,et al.  Chromosomal translocations and sarcomas , 2002, Current Opinion in Oncology.

[38]  Philippe Soriano.  Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.

[39]  T. Rabbitts,et al.  The Mll–AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis , 1999, The EMBO journal.

[40]  A T Look,et al.  Oncogenic transcription factors in the human acute leukemias. , 1997, Science.

[41]  J. Hata,et al.  A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. , 1996, Biochemical and biophysical research communications.

[42]  Y. Hayashi,et al.  An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  K. Akashi,et al.  MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. , 2004, Cancer cell.

[44]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[45]  I. Weissman,et al.  Chronic versus acute myelogenous leukemia: a question of self-renewal. , 2004, Cancer cell.

[46]  A. Trumpp,et al.  Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP‐mediated recombination in the mouse , 2000, EMBO reports.

[47]  A. Sandberg,et al.  Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms. , 2003, Cancer genetics and cytogenetics.

[48]  T. Rabbitts,et al.  The LMO2 T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development , 2003, Molecular and Cellular Biology.

[49]  Min Ye,et al.  Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. , 2002, Developmental cell.